2006
DOI: 10.1128/aem.72.2.1310-1315.2006
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Modification of Bacillus subtilis for Production of d - chiro -Inositol, an Investigational Drug Candidate for Treatment of Type 2 Diabetes and Polycystic Ovary Syndrome

Abstract: D-chiro-Inositol (DCI) is a drug candidate for the treatment of type 2 diabetes and polycystic ovary syndrome, since it improves the efficiency with which the body uses insulin and also promotes ovulation. Here, we report genetic modification of Bacillus subtilis for production of DCI from myo-inositol (MI). The B. subtilis iolABC-DEFGHIJ operon encodes enzymes for the multiple steps of the MI catabolic pathway. In the first and second steps, MI is converted to 2-keto-MI (2KMI) by IolG and then to 3D-(3,5/4)-t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
55
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 55 publications
(56 citation statements)
references
References 21 publications
1
55
0
Order By: Relevance
“…myo-inositol, can change accumulation of other soluble carbohydrates, particularly RFOs and modify tolerance of grains and seedlings to abiotic stresses. On the other hand, D-pinitol and D-chiro-inositol indicate some health benefits both cyclitols and their galactosides can be helpful compounds in treatment of type 2 diabetes (lowering glucose level in blood), polycystic ovary syndrome (Yoshida et al 2006), and Alzheimers disease (Nitz et al 2008). Pinitol also possesses anti-inflammatory (Sethi et al 2008) and anti-viral properties (Zhan et al 2006) and has been implicated in the prevention of cardiovascular diseases (Choi et al 2009).…”
Section: Introductionmentioning
confidence: 99%
“…myo-inositol, can change accumulation of other soluble carbohydrates, particularly RFOs and modify tolerance of grains and seedlings to abiotic stresses. On the other hand, D-pinitol and D-chiro-inositol indicate some health benefits both cyclitols and their galactosides can be helpful compounds in treatment of type 2 diabetes (lowering glucose level in blood), polycystic ovary syndrome (Yoshida et al 2006), and Alzheimers disease (Nitz et al 2008). Pinitol also possesses anti-inflammatory (Sethi et al 2008) and anti-viral properties (Zhan et al 2006) and has been implicated in the prevention of cardiovascular diseases (Choi et al 2009).…”
Section: Introductionmentioning
confidence: 99%
“…Recently IolG was also shown to be able to act on D-chiro-inositol (DCI, compound [2]) to yield 1-keto-DCI (compound [4]), and IolI interconverts 1-keto-DCI and 2KMI, indicating that not only MI but also DCI is metabolized through the MI catabolic pathway ( Fig. 1) (14). In addition, pinitol (3-Omethyl-DCI) contained in soybean appeared to be an alternative substrate of IolG, and this substrate was degraded depending on the presence of functional iol genes (15).…”
mentioning
confidence: 99%
“…IolH is paralogous to both IolI and IolE. The iolI gene product was shown to be 2KMI/1-keto-DCI isomerase involved in DCI metabolism (14), and IolE is known as 2KMI dehydratase indispensable for MI catabolism (13). This suggests that IolH may also act on a certain ketose as its isomerase or dehydratase.…”
mentioning
confidence: 99%
“…In B. subtilis, the iol genes are involved in metabolism not only of myo-inositol but also of pinitol and D-chiro-inositol. 30,31) In addition, the iol genes are induced in the presence of each of these compounds. We characterized S. fredii USDA191 iolE encoding 2-ketomyo-inositol dehydratase specific for the second step in the reaction in the myo-inositol catabolic pathway, suggesting that USDA191 might possess a pathway analogous to that of B. subtilis.…”
Section: Cloning and Nucleotide Sequencing Of S Fredii Usda191 Iole mentioning
confidence: 99%